28 / 68
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 6, November/December 2015
226
AFRICA
5.
Yokozawa T, Wu Liu ZW, Dong E. A study of ginsenoside-Rd in a renal
ischemia-reperfusion model.
Nephron
1998;
78
(2): 201–206.
6.
Kanko M, Maral H, Akbas MH, Ozden M, Bulbul S, Omay O,
et al
.
Protective effects of clopidogrel on oxidant damage in a rat model of
acute ischemia.
Tohoku J Exp Med
2005;
205
(2): 133–139.
7.
Hu H, Batteux F, Chéreau C, Kavian N, Marut W, Gobeaux C,
et
al
. Clopidogrel protects from cell apoptosis and oxidative damage in
a mouse model of renal ischaemia-reperfusion injury.
J Pathol
2011;
225
(2): 265–275. doi: 10.1002/path.2916.
8.
Iba T, Kidokoro A, Fukunaga M, Takuhiro K, Ouchi M, Ito Y.
Comparison of the protective effects of type III phosphodiesterase
(PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal
microcirculation after ischemia reperfusion injury in mice.
Shock
2006;
26
(5): 522–526.
9.
Caliskan A, Yavuz C, Karahan O, Yazici S, Guclu O, Demirtas S,
et al
.
Factor-Xa inhibitors protect against systemic oxidant damage induced
by peripheral-ischemia reperfusion.
J Thromb Thrombolysis
10.1007/
s11239-013-1019-4.
10. Yavuz C, Yazici S, Karahan O, Demirtas S, Caliskan A, Guclu O,
et al
.
Serum nitric oxide level could be a predictive biomarker for detection of
critical ischaemia duration.
Biomarkers
2013;
18
: 116–120.
11. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues
by thiobarbituric acid reaction.
Anal Biochem
1979;
95
: 351–358.
12. Eckerson HW, Romson J, Wyte C, La Du BN. The human serum
paraoxonase polymorphism: identification of phenotypes by their
response to salts.
Am J Hum Genet
1983;
35
: 214–227.
13. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase
assay by proline colorimetric determination: application to iminodipep-
tiduria.
Clin Chim Acta
1982;
125
: 193–205.
14. Wong A, Townley SA. Herbal medicines and anaesthesia.
Contin Educ
Anaesth Crit Care Pain
2011;
11
(1): 14–17. doi: 10.1093/bjaceaccp/mkq046
15. Mannaa F, Abdel-Wahhab MA, Ahmed HH, Park MH. Protective role
of Panax ginseng extract standardized with ginsenoside Rg3 against
acrylamide-induced neurotoxicity in rats.
J Appl Toxicol
2006;
26
(3):
198–206.
16. Rates SMK. Plants as source of drugs.
Toxicon
2001;
39
(5): 603–613.
17. Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcera-
tive colitis.
Saudi J Gastroenterol
2012;
18
(1): 3–10. doi: 10.4103/1319-
3767.91726.
18. Kizil S, Toncer O, Ipek A, Arslan N. Saglam S, Khawar KM. Blooming
stages of Turkish hyssop (Hyssopus officinalis L.) affect essential oil
composition.
Acta Agr Scand B-P S
2008;
58
: 273–279.
19. Kim JH. Cardiovascular diseases and Panax ginseng: A review on
molecular mechanisms and medical applications.
J Ginseng Res
2012;
36
(1): 16–26. doi: 10.5142/jgr.2012.36.1.16.
20. Karagüzel E, Kutlu Ö, Yulu
ğ
E, Mungan S, Kazaz
İ
O, Tok DS,
et al.
Comparison of the protective effect of dipyridamole and acetylsali-
cylic acid on long-term histologic damage in a rat model of testicular
ischemia-reperfusion injury.
J Pediatr Surg
2012;
47
(9): 1716–1723. doi:
10.1016/j.jpedsurg.2012.01.078.
21. Fu Y, Wang Z, Chen WL, Moore PK, Zhu YZ. Cardioprotective effects
of nitric oxide-aspirin in myocardial ischemia-reperfused rats.
Am J
Physiol Heart Circ Physiol
2007;
293
(3): H1545–1552.
22. Basha MP, Saumya SM. Influence of fluoride on streptozotocin induced
diabetic nephrotoxicity in mice: protective role of Asian ginseng (Panax
ginseng) & banaba (Lagerstroemia speciosa) on mitochondrial oxidative
stress.
Indian J Med Res
2013;
137
(2): 370–379.
23. Uluba
ş
B, Cimen MY, Apa DD, Sarita
ş
E, Mu
ş
lu N, Cimen OB. The
protective effects of acetylsalicylic acid on free radical production in
cisplatin induced nephrotoxicity: an experimental rat model.
Drug Chem
Toxicol
2003;
26
: 259–270.
24. Taher MA, Nassir ES. Beneficial effects of clopidogrel on glycemic indi-
ces and oxidative stress in patients with type 2 diabetes.
Saudi Pharm J
2011;
19
: 107–113. doi: 10.1016/j.jsps.2011.01.006.
25. Yazici S, Demirtas S, Guclu O, Karahan O, Yavuz C, Caliskan A,
et
al
. Using oxidant and antioxidant levels to predict the duration of
both acute peripheral and mesenteric ischemia.
Perfusion
2014;
29
(5):
450–455. doi: 10.1177/0267659114524012.
26. Tselepis AD, Tsoumani ME, Kalantzi KI, Dimitriou AA, Tellis CC,
Goudevenos IA. Influence of high-density lipoprotein and paraoxo-
nase-1 on platelet reactivity in patients with acute coronary syndromes
receiving clopidogrel therapy.
J Thromb Haemost
2011;
9
: 2371–2378.
doi: 10.1111/j.1538-7836.2011.04541.x.
27. Yavuz C, Güçlü O, Demirta
ş
S, Karahan O, Yazıcı S, Çalı
ş
kan A,
et
al
. Can elevated prolidase activity predict the duration of ischemic
exposure in different types of ischemia?
Turk Gogus Kalp Dama
2013;
21
: 1000–1004.
28. Ali MB, Hahn EJ, Paek KY. Protective role of Panax ginseng extract on
lipid peroxidation and antioxidant status in polyethylene glycol induced
Spathiphyllum leaves.
Biochem. Eng
J
2006;
32
(3): 143–148.
29. Suzuki Y, Inoue T, Ra C. NSAIDs, mitochondria and calcium signaling:
special focus on aspirin/salicylates.
Pharmaceuticals
2010;
3
: 1594–1613;
doi:10.3390/ph3051594.
30. Bruning RS, Dahmus JD, Kenney WL, Alexander LM. Aspirin and
clopidogrel alter core temperature and skin blood flow during heat
stress.
Med Sci Sports Exerc
2013;
45
(4): 674–682. doi: 10.1249/
MSS.0b013e31827981dc.
31. Heitzer T, Rudolph V, Schwedhelm E, Karstens M, Sydow K, Ortak M,
et al
. Clopidogrel improves systemic endothelial nitric oxide bioavail-
ability in patients with coronary artery disease: evidence for antioxidant
and antiinflammatory effects.
Arterioscler Thromb Vasc Biol
2006;
26
(7):
1648–1652.
32. Taubert D, Berkels R, Grosser N, Schröder H, Gründemann D, Schömig
E. Aspirin induces nitric oxide release from vascular endothelium: a
novel mechanism of action.
Br J Pharmacol
2004;
143
(1): 159–165.
33. Bonello L, Harhouri K, Sabatier F, Camoin-Jau L, Arnaud L,
Baumstarck-Barrau K,
et al
. Level of adenosine diphosphate receptor
P2Y12 blockade during percutaneous coronary intervention predicts
the extent of endothelial injury, assessed by circulating endothe-
lial cell measurement.
J Am Coll Cardiol
2010;
56
(13): 1024–1031. doi:
10.1016/j.jacc.2010.01.072.
34. Grosser N, Schröder H. Aspirin protects endothelial cells from oxidant
damage via the nitric oxide-cGMP pathway.
Arterioscler Thromb Vasc
Biol
2003;
23
(8): 1345–1351.